Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics

Monday, a coalition of CF patients and their families, helmed by Vertex Save Us and U.K.-based patient advocacy group Just Treatment, petitioned governments in South Africa, Brazil, India and Ukraine to either revoke or suspend Vertex patents surrounding the company’s Trikafta.